Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$31,213,334
-$3,817,326 QoQ
Shares Held
420,325
-8.2% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GILDER GAGNON HOWE & CO LLC holds $340,397,266 across 19 Biotechnology names. BBIO ranks #3 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
4,304,010 | $101,402,475 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,092 | $92,674,040 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
This page
|
420,325 | $31,213,334 | |
| 4 | CYTK |
Cytokinetics Inc
|
330,989 | $21,815,484 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
235,433 | $19,609,214 | |
| 6 | NKTR |
Nektar Therapeutics
|
271,758 | $19,552,988 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
29,391 | $15,385,306 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
40,128 | $10,365,864 |
All Filings in BBIO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,213,334 | 420,325 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,030,660 | 457,977 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,012,433 | 462,311 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,096,015 | 465,401 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,225,940 | 122,243 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,350,871 | 49,230 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,258,029 | 49,412 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,122,169 | 44,302 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,400,645 | 45,299 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,619,725 | 40,122 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,058,122 | 40,126 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $611,563 | 35,556 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $527,907 | 31,840 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $247,947 | 32,539 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $481,096 | 48,400 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $442,631 | 48,748 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,577,511 | 845,075 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,098,936 | 845,260 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $35,401,942 | 755,322 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $46,206,034 | 757,973 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $47,109,647 | 764,767 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||